HBLRX
Price
$14.78
Change
+$0.07 (+0.48%)
Updated
Jun 30 closing price
Net Assets
11.84B
JNBCX
Price
$10.13
Change
+$0.03 (+0.30%)
Updated
Jun 30 closing price
Net Assets
8.29B
Interact to see
Advertisement

HBLRX vs JNBCX

Header iconHBLRX vs JNBCX Comparison
Open Charts HBLRX vs JNBCXBanner chart's image
Hartford Balanced Income R3
Price$14.78
Change+$0.07 (+0.48%)
VolumeN/A
Net Assets11.84B
JPMorgan Income Builder C
Price$10.13
Change+$0.03 (+0.30%)
VolumeN/A
Net Assets8.29B
HBLRX vs JNBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HBLRX vs. JNBCX commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLRX is a Buy and JNBCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLRX has more cash in the bank: 11.8B vs. JNBCX (8.29B). JNBCX pays higher dividends than HBLRX: JNBCX (5.22) vs HBLRX (2.96). HBLRX was incepted earlier than JNBCX: HBLRX (15 years) vs JNBCX (18 years). JNBCX (1.57) is less costly to investors than HBLRX (1.28). JNBCX is a more actively managed with annual turnover of: 107.00 vs. HBLRX (61.00). HBLRX has a lower initial minimum investment than JNBCX: HBLRX (0) vs JNBCX (1000). JNBCX annual gain was more profitable for investors over the last year : 9.84 vs. HBLRX (5.32). JNBCX return over 5 years is better than : 23.08 vs. HBLRX (15.26).
HBLRXJNBCXHBLRX / JNBCX
Total Expense Ratio1.281.25102%
Annual Report Gross Expense Ratio1.281.5782%
Fund Existence15 years18 years-
Gain YTD4.7336.40374%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B8.29B142%
Annual Yield % from dividends2.965.2257%
Returns for 1 year5.329.8454%
Returns for 3 years13.6322.9759%
Returns for 5 years15.2623.0866%
Returns for 10 years35.5142.7483%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGAAX71.47N/A
N/A
American Funds Growth Fund of Amer R1
RYVLX591.08N/A
N/A
Rydex NASDAQ-100® 2x Strategy A
FCVAX19.30N/A
N/A
Fidelity Advisor Small Cap Value A
EUGDX29.98N/A
N/A
Morgan Stanley Europe Opportunity I
ASICX25.32N/A
N/A
Invesco EQV Asia Pacific Equity C